Illinois General Assembly - Bill Status for SB1589
Illinois General Assembly

Previous General Assemblies

 Bill Status of SB1589  102nd General Assembly


Short Description:  INS/ANTI-SEIZURE DRUG COVERAGE

Senate Sponsors
Sen. Laura Fine

Last Action
DateChamber Action
  1/10/2023SenateSession Sine Die

Statutes Amended In Order of Appearance
215 ILCS 5/356z.43 new
215 ILCS 134/25
225 ILCS 85/26


Synopsis As Introduced
Amends the Illinois Insurance Code. Provides that an individual or group policy of accident and health insurance amended, delivered, issued, or renewed after the effective date of the amendatory Act shall provide coverage for anti-epileptic drugs. Provides that coverage for anti-epileptic drugs may not impose a waiting period or any deductible, coinsurance, copayment, or other cost-sharing limitation. Defines "anti-epileptic drug", "epilepsy", and "seizure". Amends the Managed Care Reform and Patient Rights Act. Provides that anti-seizure prescription drugs may not be substituted with a generic drug under provisions of the Pharmacy Practice Act under which a pharmacist may substitute a therapeutically equivalent generic drug for a prescription drug. Amends the Pharmacy Practice Act. Provides that a pharmacist may not interchange an anti-epileptic drug or formulation of an anti-epileptic drug for the treatment of epilepsy. Provides that a prescribing physician shall document that such anti-epileptic drug or formulation of an anti-epileptic drug for the treatment of epilepsy is clinically necessary for the patient's optimal care. Removes provisions concerning notification and consent required when a physician substitutes a generic prescription in place of a brand-name anti-epileptic drug.

Actions 
DateChamber Action
  2/26/2021SenateFiled with Secretary by Sen. Laura Fine
  2/26/2021SenateFirst Reading
  2/26/2021SenateReferred to Assignments
  3/9/2021SenateAssigned to Insurance
  4/16/2021SenateRule 3-9(a) / Re-referred to Assignments
  1/10/2023SenateSession Sine Die

Back To Top